Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Non-Current Assets (2016 - 2025)

Ligand Pharmaceuticals' Non-Current Assets history spans 16 years, with the latest figure at -$832.3 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 236.39% year-over-year to -$832.3 million; the TTM value through Dec 2025 reached $872.7 million, down 60.69%, while the annual FY2025 figure was -$832.3 million, 236.39% down from the prior year.
  • Non-Current Assets for Q4 2025 was -$832.3 million at Ligand Pharmaceuticals, down from $610.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $857.7 million in Q1 2021 and bottomed at -$832.3 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $610.2 million (2024), against an average of $581.4 million.
  • The largest annual shift saw Non-Current Assets soared 141.47% in 2021 before it tumbled 236.39% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $832.8 million in 2021, then tumbled by 40.08% to $499.1 million in 2022, then increased by 10.16% to $549.8 million in 2023, then increased by 10.99% to $610.2 million in 2024, then crashed by 236.39% to -$832.3 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Non-Current Assets are -$832.3 million (Q4 2025), $610.2 million (Q4 2024), and $545.0 million (Q1 2024).